Jin Medical International (ZJYL) Current Deferred Revenue (2022 - 2026)
Jin Medical International (ZJYL) posted Current Deferred Revenue of $495357.0 for Q3 2025, up 43.0% sequentially from $346410.0 in Q1 2025, and down 26.22% YoY from $671414.0 in Q3 2024.
Jin Medical International (ZJYL) Current Deferred Revenue (2022 - 2026) Analysis & Trends
Jin Medical International has reported Current Deferred Revenue for 4 years, with the latest figure at $495357.0 in Q3 2025.
- Quarterly Current Deferred Revenue fell 26.22% year-over-year to $495357.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $495357.0 (down 26.22% YoY) and the FY2025 annual result came in at $495357.0, down 26.22% from the prior year.
- Current Deferred Revenue grew to $495357.0 in Q3 2025 per ZJYL's latest filing, from $346410.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $830305.0 in Q3 2022 and troughed at $346410.0 in Q1 2025.
- A 4-year average of $594531.3 and a median of $561146.0 in 2023 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue slipped 2.52% in 2024, then slumped 36.67% in 2025.
- Over 4 years, Current Deferred Revenue stood at $830305.0 in 2022, then retreated by 14.48% to $710099.0 in 2023, then dropped by 5.45% to $671414.0 in 2024, then decreased by 26.22% to $495357.0 in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $495357.0, $346410.0, and $671414.0 for Q3 2025, Q1 2025, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Jin Medical International | 24.19 Mn | -57.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 452,720.00 |
| Sep 30, 2025 | 495,357.00 |
| Mar 31, 2025 | 346,410.00 |
| Sep 30, 2024 | 671,414.00 |
| Mar 31, 2024 | 546,988.00 |
| Sep 30, 2023 | 710,099.00 |
| Mar 31, 2023 | 561,146.00 |
| Sep 30, 2022 | 830,305.00 |